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1. Introduction 
Labour is the climax of pregnancy resulting in the expulsion of the fetus from the uterus. It 
is a complex process and the mechanisms involved in the initiation of labour are poorly 
understood despite decades of investigation. Generally, labour is not a sudden occurrence 
but one for which the body prepares: numerous physiological, biochemical and 
immunological events take place at the materno-fetal interface, and in both mother and fetus 
in the lead up to parturition (Hendricks, Brenner et al. 1970). These same processes might be 
accelerated or other pathways brought into play when labour occurs prematurely. The bulk 
of perinatal morbidity and mortality is associated with premature labour and delivery of a 
preterm infant (Tucker and McGuire 2004; Steer 2005). Understanding the mechanisms of 
labour in health and in adverse obstetric outcomes should provide insight into the 
pathogenesis of preterm birth.  
2. Labour, inflammation and cytokines  
Human labour and delivery have been compared to an inflammatory response (Aboussahoud, 
Bruce et al. 2010; Liggins, Fairclough et al. 1973) of at least three physiologically 
interdependent processes: remodelling of the cervix to allow it to stretch open to the width 
of the reproductive tract, weakening and rupture of the membranes in the region that 
overlies the cervix, and the initiation of rhythmic contractions of increasing amplitude and 
frequency that ultimately force the fetus and placenta from the uterus. Pro-inflammatory 
cytokines have a role in most of these processes, suggesting that the immune privileges that 
the fetal-placental unit has enjoyed during pregnancy might be revoked at the time of 
labour (Aboussahoud, Bruce et al. 2010; Bayraktar, Peltier et al. 2009). Other beneficial 
effects of strong pro-inflammatory activity during labour could include removal of placental 
fragments and a heightened innate immune response in the postpartum uterus to combat 
the pathogens undoubtedly encountered at this time. 
2.1 Cervical ripening 
Re-modelling of the extracellular matrix, including decreased collagen concentration and the 
dispersion of collagen fibrils, is a feature of cervical ripening (Leppert 1995; Winkler and 
Rath 1999). This is facilitated by increased local production of many pro-inflammatory 
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cytokines and chemokines, such as interleukin-1 (IL-1, IL-6, IL-8, monocyte chemotactic 
protein-1 (MCP-1; CCL2) and tumour necrosis factor  (TNF (Osman, Young et al. 2003; 
Tornblom, Klimaviciute et al. 2005), and an influx of neutrophils and macrophages that also 
secrete cytokine and chemokines and amplify the inflammatory response via the 
recruitment of other inflammatory cells to the cervix (Rodney W; Sennstrom, Brauner et al. 
1997; Sakamoto, Moran et al. 2005). Cytokines such as TNF and IL-1 activate the nuclear 
factor (NF)B pathway, leading to increased production of proteases, cathepsins and matrix 
metalloproteinases (MMPs), that allow for the digestion of collagen (Watari, Watari et al. 
1999). Inhibitors of MMP are down-regulated by IL-1 and IL-1 also increases production 
of cyclooxygenase (COX)-2 and prostaglandin E2 (PGE2) which further increases production 
of proteinases and modulates leukocyte trafficking (Sato, Michizu et al. 2001). Murine 
models show that mechanisms regulating cervical ripening might differ in preterm and term 
birth, and with underlying cause of labour: preterm birth subsequent to progesterone 
withdrawal in the absence of infection was comparable to term cervical ripening but 
preterm ripening in response to infection (using lipopolysaccharide (LPS)) was associated 
with a robust pro-inflammatory response including neutrophil influx and activation of the 
prostaglandin synthesis cascade (Holt, Timmons et al. 2011).  
2.2 Membrane rupture 
Membrane rupture is also characterised by extracellular matrix remodeling: fibronectin is 
degraded by MMPs and other proteases (Lockwood, Senyei et al. 1991; Vadillo-Ortega, 
Hernandez et al. 1996) facilitating separation of the previously fused chorioamniontic 
membranes and deciduas. Similar to the cervix, production of MMPs is increased in 
response to the augmented production of pro-inflammatory cytokines such as IL-8, IL-6, 
TNF and IL-1 (Laham, Brennecke et al. 1996a, 1996b, 1999.). Inflammatory cytokines 
decrease rupture strength of fetal membranes. This is achieved by induction of 
prostaglandin and reactive oxygen species production, and collagen remodelling via the 
release of proteases such as MMP9 (Moore, Novak et al. 2009). 
2.3 Myometrial contractions 
A similar pattern of cytokine activity is observed in the myometrium: increased levels of IL-
6, IL-1, TNF and IL-8 result in increased production of COX-2 and PGE2 (Pollard and 
Mitchell 1996; Young, Thomson et al. 2002). IL-6 in particular promotes increased 
production of oxytocin and expression of the oxytocin receptor by myometrial cells (Friebe-
Hoffmann, Chiao et al. 2001). PGE2 and oxytocin in combination are responsible for 
intracellular calcium increase which are essential for contractions (Thornton, Gillespie et al. 
1992). 
3. Preterm birth  
Birth prior to 37 weeks of gestation is the leading cause of perinatal morbidity and mortality 
in the Western world; 75% of perinatal mortality and nearly 50% of long-term neurological 
morbidity are associated with preterm birth (PTB) (Goldenberg, Culhane et al. 2008). 
Preterm infants are prone to higher rates of complications of the gastrointestinal, renal and 
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respiratory systems (Saigal and Doyle 2008). Increasing PTB rates over the past 30 years in 
industrialised countries reflects increased indicated preterm births for reasons such as 
preeclampsia and intrauterine growth restriction (IUGR), and the fallout of multiple gestations 
associated with assisted reproductive technologies (ART). Other risk factors for preterm birth 
include ethnicity, previous preterm birth, low maternal body mass index (BMI), genetic 
variation, infection including periodontal disease, and adverse behaviours. Annual estimates 
currently suggest that 12.9 million (about 10%) infants worldwide are born prematurely (Beck, 
Wojdyla et al. 2010). The prevention and management of PTB is one of the major challenges of 
contemporary obstetrics and gynaecology. PTB also has a large economic impact. The cost of 
preterm birth to the public sector in England and Wales is approximately £3 billion; the 
average preterm baby is one and a half times more costly than a full term neonate with the 
estimated incremental cost per PTB infant at around £30,000 in England and Wales 
(Mangham, Petrou et al. 2009). Recent decades have seen improvements in the survival rates 
of preterm infants due to advances in neonatal care and the increased use of antenatal 
steroids but little change in the ability to prevent preterm birth (Elovitz and Mrinalini 2004). 
Preterm delivery for maternal and/or fetal indications accounts for around 30% of preterm 
births (Hamilton, Martin et al. 2006). Other obstetric precursors of preterm birth are 
spontaneous preterm labour (sPTL) with intact membranes and preterm premature rupture 
of the membranes (PPROM). Spontaneous preterm labour, defined as regular uterine 
contractions with accompanying cervical changes before 37 weeks gestation accounts for 
45%, while PPROM, defined as spontaneous membrane rupture accounts for 15% 
(Goldenberg, Culhane et al. 2008). Both sPTL and PPROM are the outcome of maternal 
and/or fetal inflammatory responses that can have a systemic component or remain 
localised to the reproductive tract.  
Intrauterine infection is a common mechanism of preterm labour accounting for 25 – 40% of 
all sPTL cases, although limitations in microbiological culture techniques might make this a 
conservative estimate (Goldenberg, Hauth et al. 2000). Several routes have been suggested 
for microbial invasion into the intrauterine cavity. The most common route is the ascension 
of microorganisms from the vagina through the cervix and into the uterus. The infection can 
ultimately gain access to the amniotic fluid thereby exposing the fetus to infection (Kim, 
Romero et al. 2009). Other routes of infection include hematogenous spread through the 
placenta of non-genital tract infections such as those from the oral cavity (Bearfield, 
Davenport et al. 2002). Irrespective of the route, microbial invasion results in infection at 
various sites including the placenta, the fetal membranes, the amniotic fluid, the umbilical 
cord, and the fetus itself. Many microorganisms have been associated with PPROM, sPTL 
and PTB. Common microorganisms resulting in intrauterine infection include Escherichia coli 
(Naeye 1979), Ureaplasma urealyticum (Yoon, Romero et al. 1998), Streptococcus agalactiae 
(Gibbs, Romero et al. 1992) and Chlamydia trachomatis (Gibbs, Romero et al. 1992) among 
many others. For example, genital mycoplasmas have been associated with a higher 
maternal white blood count and C-reactive protein (CRP), and more leukocytes in the 
amniotic fluid (Oh, Lee et al. 2010). 
4. Inflammation and cytokines in healthy and adverse pregnancy outcomes 
A wealth of evidence indicates that labour is an inflammatory process (Bowen, Chamley et 
al. 2002). Inflammation is a primary response mechanism resulting from the biological 
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activity of cytokines and other mediators produced in response to harmful stimuli of both 
infectious and non-infectious origins. Cytokines are small proteins secreted by various cells 
that function as extracellular signalling molecules to facilitate communication between 
various cells of the body, a response induced by binding to specific receptors expressed by 
target cells. Cytokines including IL-6, IL-8 and TNF are key immunological and 
inflammatory mediators which can act in an autocrine, paracrine or endocrine manner.  
The pathophysiological mechanisms underlying preterm birth are largely unknown but 
might relate to premature activation of the normal labour process or the response to an 
insult. Proposed triggers of preterm birth include: uterine over-distension, stress, infection 
and inflammation, and other immunologically-mediated processes. Irrespective of the 
triggering event, local and systemic inflammation tends to be a feature of preterm labour 
and delivery. Understanding the inflammatory pathways that contribute to the initiation 
and maintenance of preterm (and term) labour could be used to develop strategies to: (i) 
identify those women most at risk of preterm labour and birth, and (ii) prevent preterm 
birth. Whilst infection-associated PTB is the focus of this chapter, clinical studies have 
revealed an association between infection and other pregnancy complications such as 
preeclampsia and IUGR (Hsu and Witter 1995; Arechavaleta-Velasco, Koi et al. 2002). 
A burgeoning body of literature implicates numerous cytokines in the normal physiological 
processes of pregnancy (e.g. implantation, placental function, parturition) and in the 
inflammatory response during infection associated preterm labour. The analysis of changes 
in candidate cytokines has proved worthwhile in identifying potential underlying 
mechanisms of PTB. IL-1, the first cytokine implicated, is up-regulated in response to 
microbial products in the human decidua, resulting in the production of prostaglandins by 
the amnion and deciduas (Romero, Brody et al. 1989a; Romero, Durum et al. 1989b; Romero, 
Wu et al. 1989c). Mid-trimester amniotic fluid levels of IL-1 levels are associated positively 
with preterm delivery (Puchner, Iavazzo et al. 2011), and IL-6 concentrations in amniotic 
fluid are considered a marker for infection (Romero, Avila et al. 1990; Yoon, Romero et al. 
1995). Other cytokines including IL-10 (Gotsch, Romero et al. 2008), TNF (Romero, 
Manogue et al. 1989d), colony stimulating factor (CSF) (Saito, Kato et al. 1992) and IL-18 
(Pacora, Romero et al. 2000) among others have been linked to infection associated preterm 
labour. There are now a number of groups developing strategies to identify cytokine and 
other protein signatures that might rapidly identify those women most at risk of delivering 
prematurely especially in the setting of intrauterine infection. Mass spectrometry-based 
proteomic profiling of amniotic fluid from women with PTL or PPROM found an inverse 
relationship between time to delivery and severity of intra-amniotic inflammation as 
determined by measurement of 4 biomarkers. While minimal inflammation was also 
associated with preterm birth, the extent of intra-amniotic inflammation correlated with 
negative outcomes for the neonate (Buhimschi, Bhandari et al. 2007). The potential of 
proteomic profiling of cervico-vaginal fluid also has been evaluated in a non-human primate 
model of intra-amniotic infection. Differential expression of proteins was observed in 
control versus infected samples and this might offer a relatively non-invasive strategy for 
detection of infection via signatures created by specific biomarkers (Gravett, Thomas et al. 
2007). 
The cytokines of interest are made by cells normally present in the gestation-associated 
tissues such as trophoblast cells and macrophages, and by leukocytes that infiltrate these 
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tissues in response to inflammatory stimuli. An accumulation of leukocytes evident upon 
histological analysis of the placental membranes, so-called chorioamnionitis, occurs in 
around one-third of preterm deliveries. Chorioamnionitis was once considered a hallmark 
of infection but it was soon recognised to occur in the absence of any detectable signs of 
infection. Now, two types of chorioamnionitis have been classified: acute chorioamnionitis 
(ACA) associated with infection, and chronic chorioamnionitis (CCA) of immunologic origin 
related to maternal anti-fetal allograft rejection and graft-versus-host disease in the placenta 
(Lee, Romero et al. 2011). The local cytokine profile differs with the type of 
chorioamnionitis: IL-6 is the prototypic cytokine elevated in amniotic fluid in ACA whereas 
for CCA amniotic fluid levels of CXCL10 (IP-10 – interferon-inducible protein-10) are 
increased and there is elevated gene expression of CXCL9 (MIG – monokine induced by 
interferon gamma), CXCL10 and CXCL11 (I-TAC - interferon-inducible T-cell alpha 
chemoattractant) (Kim, Romero et al. 2010).  
While chorioamnionitis generally is associated with adverse pregnancy outcomes, around 9 
- 20% of term deliveries have evidence of histologic chorioamnionitis and the duration of 
labour might impact on the occurrence of this (Lee 2011, Romero et al.; Park, Romero et al. 
2010). Notably chorioamnionitis is also increased in spontaneous versus induced preterm 
birth (Kim, Romero et al. 2010). Preterm chorioamnionitis is accompanied by villitis in 
around 40% of cases (Kim, Romero et al. 2010). Placental villous macrophages (Hofbauer 
cells) in particular increase when there is evidence of chorioamnionitis. It has been 
suggested that fibroblast production of MCP-1 in response to bacterial products such as LPS 
or inflammatory cytokines such as IL-1 or TNF might drive the accumulation of 
macrophages within placental villi in this setting (Toti, Arcuri et al. 2011). 
5. The innate immune response and inflammation: pattern recognition 
receptors and cytokine production 
Changes in cytokine production at the maternal-fetal interface are a feature of both term and 
preterm labour. This has generated much interest in the mechanisms of cytokine production 
in the placenta and attached membranes, and whether such changes precede labour or are 
simply a consequence of it. Signalling pathways of the innate immune system which 
produce a defined cytokine output in response to microbial stimuli have been postulated as 
central to this. Several studies have found a link between the treatment of various gestation-
associated tissues with microbial stimuli and cytokine outputs (Holmlund, Cebers et al. 
2002; Wang and Hirsch 2003; Elovitz and Mrinalini 2004; Kim, Romero et al. 2004; 
Kumazaki, Nakayama et al. 2004). These studies have shown that microbial products such 
as LPS can trigger key molecular events ultimately leading to the production of relevant 
cytokines.  
The innate immune system uses evolutionary conserved germline encoded receptors, 
termed pattern recognition receptors (PRRs), to recognise and respond to a variety of 
pathogenic and non-pathogenic microorganisms. Identification of PRRs was initially 
demonstrated by work on the Drosophila protein Toll, a protein involved in development of 
dorsoventral polarity during embryonic development. However, Hoffman and colleagues 
demonstrated that Toll was also required for an effective immune response to Aspergillus 
fumigates in the fly (Lemaitre, Nicolas et al. 1996). This realisation inspired a search for 
mammalian homologues of Toll, which lead to the discovery initially of Toll-like receptor 4 
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(TLR4), and consequently the remainder of the Toll-like receptor family (TLRs) (Medzhitov, 
Preston-Hurlburt et al. 1997). As increasing research attention has been placed on the 
mechanisms of innate immune recognition and signalling, other pattern recognition families 
have been discovered. These include; RIG-I (retinoic acid-inducible gene I)-like receptors 
(RLRs) (Yoneyama and Fujita 2007), NOD (nucleotide oligomerisation domain)-like 
receptors (NLRs) (Mathews, Sprakes et al. 2008), C-type lectin receptors (CLRs) (Netea, 
Ferwerda et al. 2005) and DAI (DNA dependent activator of IFN regulatory factors)-like 
receptors (DLRs) (Takaoka, Wang et al. 2007). Each family of PRRs has numerous members.  
PRRs detect conserved molecular patterns called pathogen associated molecular patterns 
(PAMPs) on a wide range of pathogens. Detection of a PAMP by its specific PRR, activates 
intracellular signalling, leading to cytokine gene expression and eventual activation of 
inflammatory and antimicrobial responses (Ishii, Koyama et al. 2008). Examples of PAMPs 
include lipopolysaccharide (LPS), a cell wall component of Gram-negative bacteria, and 
peptidoglycan (PGN), a component of Gram-positive bacteria cell walls (Janeway and 
Medzhitov 2002). PRRs have also been shown to recognise damage associated molecular 
pattern patterns (DAMPs) released by the host (Bianchi 2007).  
Below is an overview of each PRR family including some detail about cellular expression, 
signalling pathways, and the exogenous and endogenous ligands that might initiate activity 
via each pathway. This will be too much detail for some readers but for others will provide 
some insight into the constantly growing complexity of the innate immune response. 
Following this we review the current knowledge of expression and activity of components 
of each of these pathways/families in gestation-associated tissues. 
5.1 Toll-like Receptors  
The first characterised mammalian TLR was TLR4, and a further 12 mammalian TLRs have 
since been identified (Akira 2004). Only TLRs 1 – 10 are expressed and functional in 
humans. TLRs 1-9 are functional in both human and mice, however TLR10 is likely non-
functional in mice due to substitution of the C-terminal half of the mouse TLR10 gene with a 
non-productive sequence. In contrast, a stop codon in the human TLR11 gene, results in the 
gene not being expressed, while mouse TLR11 is functional and has a role in urogenital tract 
infections in particular (Zhang, Zhang et al. 2004). Stimulation of TLRs by their specific 
PAMPs initiates an intracellular signalling cascade involving numerous proteins, most 
notably MyD88. Activation of these signalling molecules ultimately leads to the activation of 
NFB and other transcription factors to induce the production of inflammatory cytokines. 
TLRs are type I transmembrane glycoproteins. The extracellular N-terminal end of all TLRs 
is composed of leucine-rich repeats (LRRs), which mediate PAMP binding and receptor 
dimerisation (Akira 2004). The LRR domain is composed of 19-25 tandem LRR motifs, of 24-
29 amino acids in length (Matsushima, Tanaka et al. 2007). The mechanisms by which TLRs 
can differentiate between PAMPs or how any one TLR can respond to multiple PAMPs are 
only now being revealed. It has been suggested that specific ligand binding sites are created 
in each TLR by specific insertions of the PAMP into the LRR (Bell, Mullen et al. 2003). The 
conserved cytoplasmic region of each TLR is termed the Toll/IL-1 receptor (TIR) domain 
due its similarity to the cytoplasmic domains of the interleukin-1 receptor family. The TIR 
domain varies between 135 and 160 amino acids in length and functions as a binding site for 
downstream adaptor molecules (Akira and Takeda 2004). 
www.intechopen.com
 
Cytokines and the Innate Immune Response at the Materno-Fetal Interface 
 
187 
TLRs can be characterised into two groups based on their cellular location and ligand 
specificity: plasma membrane localised TLRs - 1, 2, 4, 5 and 6 – that generally recognise lipid 
based PAMPs; TLRs localised to intracellular endosomes - 3, 7, 8 and 9 – that recognise 
nucleic acid based PAMPs. While the ligand(s) for TLR10 are unknown its localisation to the 
plasma membrane suggests these would be lipid based. 
The most extensively studied member of the TLR family is TLR4. TLR4 is expressed on 
various haematopoietic cells including monocytes, macrophages, polymorphonuclear 
(PMN) cells, dendritic cells, and B cells. It is also expressed by non-haematopoietic cells 
including epithelial cells and fibroblasts (Ospelt and Gay 2010). TLR4 predominantly 
recognises lipopolysaccaride (LPS), a cell wall component of Gram-negative bacteria, 
composed of O-antigen, lipid A (endotoxin) and an oligosaccharide core (Hoshino, Takeuchi 
et al. 1999). TLR4 recognition of LPS requires formation of a complex with CD14 and MD2 
(Shimazu, Akashi et al. 1999). MD2 binds to the extracellular region of TLR4, enabling it to 
bind to the lipid A component of LPS. CD14, a glycosyl phosphatidylinositol (GPI)-
anchored, high affinity membrane protein, binds LPS in the presence of LPS-binding protein 
(LBP). LBP exchanges monomers of LPS for other lipids bound in its lipid binding site prior 
to transferring the LPS monomers to CD14. This enables CD14 to concentrate the LPS which 
is released from the bacterium in small amounts prior to presenting the LPS to the TLR4-
MD2 complex (Lu, Yeh et al. 2008). TLR4 also has been implicated in the detection of fungal 
PAMPs including glucuronoxylomannan of Cryptococcus neoformans, and mannan derived 
from Saccharomyces cerevisiae and Candida albicans (Netea, Van Der Graaf et al. 2002). 
TLR2, which has a similar expression profile to TLR4, recognises a variety of PAMPs from 
both Gram-positive and Gram-negative bacteria including lipoproteins/lipopeptides and 
peptidoglycan, glycolipids, lipoteichoic acid and non-endobacterial LPS (Takeuchi, Hoshino et 
al. 1999). TLR2 also recognises fungal PAMPs including cell surface phospholipomannan of C. 
albicans, and S. cerevisiae derived zymosan (Netea, Van Der Graaf et al. 2002; Netea, Van der 
Graaf et al. 2004). TLR2 forms a heterodimer with its structural relatives, TLR1 or TLR6 
(Takeuchi and Akira; Takeuchi, Kawai et al. 1999). These heterodimers - TLR2/TLR1 and 
TLR2/TLR6 - can detect subtle variations in the lipid component of lipoproteins: tri-acetylated 
lipopeptides by TLR2/TLR1 and di-acetylated lipopeptides by TLR2/TLR6 (Takeuchi and 
Akira). Recognition of di-acetylated lipopeptides by TLR2/TLR6, is facilitated by the co-
receptor CD36, a class II scavenger protein (Hoebe, Georgel et al. 2005). Expression patterns of 
TLR1 and TLR6 are similar to that of TLR2, although it has been shown that they are both 
highly expressed on B cells, while TLR2 is not (Ospelt and Gay 2010). However the regulation 
of TLR2 expression differs between various cell types depending on their specific function, 
which is not the case for TLR1 and TLR6 (Ospelt and Gay 2010). 
TLR5 recognises bacterial flagellin, a structural protein which is the major component of 
flagella of Gram-negative bacteria (Hayashi, Smith et al. 2001). Recognition of flagellin by 
TLR5 is possibly via highly conserved regions in the flagellin protein (Hawn, Verbon et al. 
2003). A common stop codon in TLR5 is associated with loss of signalling to flagellin and 
increased susceptibility to pneumonia caused by Legionella pneumophila (Hawn, Verbon et al. 
2003). In addition to the conventional expression of TLR5 by haematopoietic cells, TLR5 is 
expressed on the basolateral surface of healthy human intestinal epithelium, suggesting that 
bacterial recognition by TLR5 only occurs as the bacteria invade across the epithelium 
(Gewirtz, Navas et al. 2001). 
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TLR3 is involved in the recognition of double-stranded RNA (dsRNA) from double-
stranded viruses, such as reovirus, or that are generated during viral replication of single 
stranded viruses (Alexopoulou, Holt et al. 2001; Wang, Town et al. 2004). Multiple 
haematopoietic cells, such as dendritic cells, and non-haematopoietic cells, such as epithelial 
cells, express TLR3 which is located within endosomes. Recognition of dsRNA by TLR3 was 
first demonstrated using TLR3 deficient mice, which showed susceptibility to mouse 
cytomegalovirus (Tabeta, Georgel et al. 2004). The type I interferon (IFN) inducing dsRNA 
synthetic analog, polyinosine-deoxycytidylic acid (poly I:C) is often used in vitro to induce 
TLR3 activity (Alexopoulou, Holt et al. 2001). 
TLR7 and TLR8 are structurally highly conserved and recognise uridine or guanosine-rich 
single stranded RNAs from a variety of viruses, including the influenza virus and human 
immunodeficienty virus (HIV) (Heil, Ahmad-Nejad et al. 2003; Heil, Hemmi et al. 2004; 
Lund, Alexopoulou et al. 2004). Additionally, they can recognise several synthetic 
imidazoquinoline-like molecules, such as resiquimod, which have potent antiviral activities 
due to their structural similarity to ribonucleic acids. While TLR7 and TLR8 recognise viral 
nucleic acid structures (Diebold, Kaisho et al. 2004; Heil, Hemmi et al. 2004) their expression 
within endosomes prohibits, under normal circumstances, interaction with host derived 
ssRNA. 
TLR9 recognises the commonly found unmethylated CpG motifs of single-stranded DNA 
present in the genomes of many viruses and bacteria (Lund, Sato et al. 2003; Hochrein, 
Schlatter et al. 2004; Krug, Luker et al. 2004). DNA viruses shown to induce inflammatory 
cytokine and type 1 IFN production via TLR9, include Herpes simplex virus-1 (HSV-1), 
HSV-2 and murine cytomegalovirus (MCM). Two structurally different forms of CpG exist: 
A-type CpG oligodeoxynucleotides (ODNs) which stimulate plasmacytoid DCs (pDCs) to 
produce IL-12 and IFN and B-type CpG ODNs, which induce IL-6, IL-12 and TNF 
production by pDCs. In addition B-type CpG ODNs also up-regulate expression of MHC 
Class II and the costimulatory molecules CD80 and CD86 on B cells and pDCs (Verthelyi, 
Ishii et al. 2001; Krug, Luker et al. 2004). TLR9 might also recognise host derived CpGs but 
these are weak inducers of activation due to the presence of highly methylated cytosine 
bases.  
5.1.1 TLRs: recognition and response 
Binding of PAMPs leads to the dimerisation of TLRs, which triggers the activation of the 
TLR mediated signalling pathways and the expression of various genes involved in the 
immune response. As previously described TLR2 forms a heterodimer with either TLR1 or 
TLR6, the remaining TLRs form homodimers (Saitoh, Akashi et al. 2004). TLR signalling 
originates from the TIR domain of the receptor, which associates with an adaptor containing 
a TIR domain. Various adaptors have been characterised including MyD88, TRIF, TRAM 
and TIRAP; each are involved in slightly different signalling pathways, dependent on which 
TLR is activated (Watters, Kenny et al. 2007). Two principle TLR signalling pathways have 
been described: the MyD88-dependent pathway and the MyD88-independent pathway also 
known as the TRIF-dependent pathway.  
The adaptor MyD88, which has a C-terminal TIR domain in addition to an N-terminal death 
domain, associates with the TIR domain of the TLR. Upon activation of a TLR, MyD88 
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recruits IRAK-4, a member of the IL-1 receptor associated kinase (IRAK) family, via 
interactions between the death domains of both molecules. This enables activation of IRAK-
1 by IRAK-4 mediated phosphorylation. IRAK-1 then associates with TRAF6 (TNF receptor 
associated factor 6), resulting in the eventual activation of the IB kinase (IKK) complex, 
which consists of IKK, IKK and NEMO/IKK. The IKK complex induces the 
phosphorylation of IB, resulting in translocation of the nuclear transcription factor NF-B, 
from the cytosol to the nucleus. Once in the nucleus NF-B can induce expression of 
multiple inflammatory cytokines (Chen, Bhatia et al. 2006; Adhikari, Xu et al. 2007; 
Kawagoe, Sato et al. 2008). Alternatively, activation of TRAF6 can lead to the activation of 
MAP kinases, resulting in AP-1 transcription factor activation. As shown in MyD88-
deficient mice, MyD88 is vital for signalling via this pathway. A second adaptor, TIRAP 
(TIR domain-containing adaptor protein)/Mal (MyD88-adaptor-like) has been shown to be 
associated with the MyD88-dependent pathway for signalling via TLR2 and TLR4 
(Yamamoto, Sato et al. 2002). 
Evidence for a My88-independent pathway was first shown in MyD88-deficient macrophages, 
in which NFB activation was not observed but production of inflammatory cytokines was 
(Kawai, Adachi et al. 1999). Further investigation noted that TLR4 stimulation results in 
IRF3 activation, a transcription factor involved in the production of IFN (Kawai, Takeuchi 
et al. 2001). Additionally IRF3 was activated in response to dsRNA or viral infection, via 
TLR3, suggesting that both TLR3 and TLR4 can utilise a common MyD88-independent 
pathway (Yoneyama, Suhara et al. 1998). 
In addition to TIRAP/Mal, two other main adaptors have been identified as involved in the 
MyD88-independent pathway: TRIF (TIR domain containing adaptor inducing IFN) also 
known as TICAM-1 (TIR domain containing molecule), and TRAM (TRIF-related adaptor 
molecule) or TICAM-2. TRIF has been associated with MyD88-independent signalling via 
TLR3, while TRIF and TRAM are associated with MyD88-independent signalling via TLR4 
(Oshiumi, Matsumoto et al. 2003; Oshiumi, Sasai et al. 2003; Yamamoto, Sato et al. 2003). The 
TIR domain of TRIF is located in the centre of the molecule and the flanking N-terminal and 
C-terminal regions can both mediate the activation of NFB but by two different actions: the 
N-terminal region associates with TRAF6, while the C-terminal region associates with RIP1 
(receptor interacting protein) (Sato, Sugiyama et al. 2003; Meylan, Burns et al. 2004). 
Activation of the IFN promoter is exclusively via the N-terminal region in association with 
the non-canonical IKKs, TBK1 and IKKi/IKK, which mediate the phosphorylation and 
nuclear translocation of IRF3, resulting in the induction of IRF3 dependent IFN production. 
5.1.2 TLRs: negative regulation 
Excessive production of inflammatory cytokines in response to PAMPs by TLRs can lead to 
detrimental outcomes including sepsis and autoimmune disease. Thus negative regulatory 
mechanisms have developed in response to TLR-mediated signalling. Once such mechanism 
is the phenomenon known as tolerance, in which a subsequent challenge by a PAMP results 
in a reduced response. This was first documented in relation to LPS, however the exact 
mechanisms are not yet fully understood. A number of inhibitors of TLR signalling have 
also been described. One such molecule is IRAK-M. IRAK-M lacks kinase activity and 
prevents the dissociation of IRAK-1/IRAK4 from MyD88 which in turn prevents the IRAK-
1/TRAF6 complex forming (Wesche, Gao et al. 1999; Kobayashi, Inohara et al. 2002). 
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Another inhibitor SOCS1 (suppressor of cytokine synthesis) has been shown to directly 
modulate TLR signalling (Yasukawa, Sasaki et al. 2000). 
5.2 C-type Lectin Receptors (CLRs) 
CLRs are a family of receptors that recognise and bind carbohydrates in a calcium-dependent 
manner. Binding is mediated via a conserved carbohydrate recognition domain (CRD) first 
identified on circulating mannose binding lectin (MBL). Other than MBL, CLRs are primarily 
expressed on antigen presenting cells (APCs) such as macrophages and dendritic cells, and are 
involved particularly in fungal recognition and modulation of the anti-fungal innate immune 
response. CLR intracellular signalling is activated via immunoreceptor tyrosine-based 
activation (ITAM)-like motifs present in the cytoplasmic tail of the receptor or on ITAM 
containing adaptors. Examples of such CLRs include; Dectin-1, Dectin-2, macrophage-
inducible C-type lectin (MINCLE), DC-SIGN and the mannose receptor (Netea, Ferwerda et al. 
2005).  
Mannose binding lectin has two to six clusters of CRDs which facilitate the identification of 
and attachment to repetitive mannose and fucose residues found on various microorganisms. 
The fixed orientation of the CRDs requires not only the presence of these residues but their 
specific spatial arrangement to initiate interaction between MBL and the target micro-
organism. Recognition of mannose and fucose by MBL leads to the activation of the lectin 
complement pathway and enhanced polymorphonuclear cell uptake (Ji, Gewurz et al. 2005; Ji, 
Olinger et al. 2005; van Asbeck, Hoepelman et al. 2008).  
The mannose receptor (MR) has similar recognition strategies to MBL. Primarily expressed 
by macrophages and dendritic cells, the mannose receptor is a type-1 membrane protein 
with eight tandemly arranged CRD domains. These allow the recognition of various 
carbohydrates terminating in L-fucose, D-mannose and N-acetyl glucosamine (Taylor, 
Gordon et al. 2005). In addition to CRDs at the extracellular region, MR has two additional 
domains, an N-terminal cysteine-rich domain and a fibronectin II domain, these are 
involved in calcium-independent binding to sulphated sugars and collagen, respectively. 
Unlike the CRDs, these additional domains are only involved in the recognition of 
endogenous ligands and not those of microbial origin (Taylor, Gordon et al. 2005; Napper, 
Drickamer et al. 2006). The role of the MR in host defence remains a mystery: animal 
knockout models do not demonstrate an increased susceptibility to pathogens such as 
Candida albicans and mycobacteria which are known to contain MR ligands (Wojcikiewicz, 
Zhang et al. 2003; Appelmelk, den Dunnen et al. 2008).  
The most widely studied CLR is Dectin-1. Dectin-1, also known as C-type lectin domain 
family 7 member A (CLEC7A), is a small (33kDa) type II glycosylated transmembrane 
receptor with an extracellular CRD connected to a cytoplasmic ITAM-like motif by a stalk 
domain. Two functional isoforms exist - Dectin-1A, and Dectin-1B which lacks the stalk 
domain, due to alternative splicing (Herre, Gordon et al. 2004). Dectin-1 expression in 
humans can be found on myeloid cells, including neutrophils, monocytes/macrophages and 
dendritic cells, however limited expression has been noted on other cell types (Herre, 
Gordon et al. 2004). Dectin-1 recognises specifically the glucose polymers -1-3 and/or -1-
6-glucans primarily found in the cell walls of fungi, including Candida albicans and 
Saccharomyces cerevisiae, but which can also be found in the cell walls of some plants (Brown 
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and Gordon 2001). Upon binding of the appropriate PAMP, phosphorylation of Dectin-1 
occurs by a non-receptor tyrosine kinase, Src, via interaction with its ITAM motif. This leads 
to the activation of another kinase, Syk, which induces the activation of the CARD9-Bc110-
Malt1 adaptor complex leading ultimately to the activation of NFB and the production of 
pro-inflammatory cytokines (Gross, Gewies et al. 2006). In addition, activation of Dectin-1 
mediates the production of reactive oxygen species (ROS) and further modulation of 
cytokine expression via the NFAT pathway (Underhill, Rossnagle et al. 2005; Goodridge, 
Simmons et al. 2007). Attenuation of the Dectin-1 mediated pro-inflammatory response has 
been linked to internalisation of the receptor (Hernanz-Falcon, Joffre et al. 2009). It has been 
shown that signalling via Dectin-1 and TLR2/TLR6 combined enhances the response 
triggered by each receptor alone (Gantner, Simmons et al. 2003).  
Similarly to Dectin-1, ITAM-dependent signalling via MINCLE leads to the activation of 
NFB and the NFAT pathway, via recognition of numerous exogenous PAMPs and 
endogenous DAMPS, including mycobacteria, C. albicans and necrotic cells (Yamasaki, 
Ishikawa et al. 2008). The identification of necrotic and damaged cells is mediated via 
recognition of splicesome-associated protein 130 (SAP130), secreted by these cells. MINCLE 
was the first known example of a CLR that can interact with PAMPs and DAMPs 
(Yamasaki, Ishikawa et al. 2008). MINCLE and another CLR, Galectin-3, have a role in anti-
Candida defence, by recognition of -mannose, resulting in MINCLE interacting with the Fc 
receptor common -chain (FcR), leading to Syk and CARD9-depedent activation of NFB 
(Jouault, El Abed-El Behi et al. 2006; Yamasaki, Ishikawa et al. 2008). MINCLE also 
recognises the immunostimulatroy component of Mycobacterium tuberculosis - trehalose-6’6’-
dimycolate better known as cord factor (Ishikawa, Ishikawa et al. 2009). 
Other CLRs, such as DC-SIGN and Dectin-2, are involved in the recognition and uptake of 
Candida albicans by detecting highly mannose structures (McGreal, Rosas et al. 2006). DC-
SIGN, expressed primarily on monocyte-derived dendritic cells, is a type II transmembrane 
receptor with only one C-type lectin domain. DC-SIGN also interacts with Leishmania but 
has gained increasing interest because of its involvement in the recognition of several 
viruses including human immunodeficiency virus (HIV)(Geijtenbeek, van Vliet et al. 2001; 
Cambi, Gijzen et al. 2003; Koppel, van Gisbergen et al. 2005). Dectin-2 which can be found 
on myeloid cells, has been suggested to have a role in hyphal recognition (Netea, Ferwerda 
et al. 2005). In response to Candida albicans, Dectin-2 induces the production of TNF, via 
interaction with FcR (Nakahara, Nakagawa et al. 2006). Additionally, Dectin-2 has been 
implicated in Th17 inducing activity in response to Candida (Robinson, Osorio et al. 2009). 
5.3 Nod-like Receptors (NLRs) 
NLRs (also known as CATERPILLERs) consist of a large family of 23 human intracellular 
(cytosolic) PRRs, which recognise both PAMPs and/or DAMPs. Acitvation via NLRs leads 
to cytokine production via NFB, or the inflammasome (see section 5.3.1) (Ting and Davis 
2005; Kanneganti, Lamkanfi et al. 2007; Shaw, Reimer et al. 2008). NLRs have also been 
implicated in autophagy, a lysosomal degradation and cell death pathway that follows 
infection (Ting, Willingham et al. 2008). Structurally, NLRs are characterised by the presence 
of a trimodular structure: a central nucleotide binding domain (NBD) flanked by leucine 
rich repeats (LRRs) at the C-terminal and a protein binding domain - caspase activation and 
recruitment domain (CARD), baculovirus inhibitor of apoptosis protein repeat (BIR), death 
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effector domain (DED) or pyrin domain (PYD) - at the N-terminal. These N-terminal 
domains, also termed the effector region, are responsible for the protein-protein interactions 
needed to activate downstream signal transduction. NLRs can be categorised into 
subfamilies based on this effector domain including: NLRC (Nod-like receptor containing a 
CARD domain) and CIITA or NLRA (class II, major histocompatibility complex, 
transactivator) all contain CARD effector domains, while NLRPs contain a pyrin effector 
domain, and NAIPs or NLRBs contain three BIR domains (Kanneganti, Lamkanfi et al. 2007; 
Kumar, Kawai et al. 2009).  
The first identified and most widely studied NLRs are NOD1 and NOD2. These belong to 
the NLRC subfamily and are highly expressed in monocytes, macrophages and dendritic 
cells, in addition to other hematopoietic cells and epithelial cells (Fritz, Ferrero et al. 2006). 
Both NOD1 and NOD2 recognise peptidoglycan (PGN) an essential building block of Gram-
positive bacterial cell walls and to a lesser extent Gram-negative bacteria. PGN consists of 
glycan chains cross-linked via short peptides (Girardin, Travassos et al. 2003), NOD1 and 
NOD2 recognise different motifs in this structure: NOD2 recognises the conserved muramyl 
dipeptide (MDP) motif found in all PGNs (McDonald, Inohara et al. 2005), whereas NOD1 
recognises D--glutamyl-meso-DAP dipeptide (iE-DAP), which is present in all Gram-
negative, but only some Gram-positive PGNs (Chamaillard, Hashimoto et al. 2003; Benko, 
Philpott et al. 2008). NOD2 can also recognise viral ssRNA and mycobacterial N-
glycolylmuramyl dipeptides (Coulombe, Divangahi et al. 2009; Sabbah, Chang et al. 2009). 
Thus both NOD1 and NOD2 are involved in the recognition of a variety of pathogenic 
bacteria including: E. coli, Chlamydia spp, Haemophilus influenza by NOD1, and M. tuberculosis 
and Streptococcus pneumonia by NOD2 (Kumar, Kawai et al. 2009). Since the majority of these 
bacteria replicate outside of the cytoplasm where NOD1 and NOD2 are located, a mechanism 
by which PGN can cross the cell membrane to activate them is required. Although numerous 
transport proteins including PepT1, PepT2, and pannexin have been identified to facilitate 
MDP passage into the cytoplasm, an exact mechanism is not fully understood (Vavricka, 
Musch et al. 2004; Lee, Tattoli et al. 2009; Marina-Garcia, Franchi et al. 2009).  
In general, activation of NOD1 and NOD2 by their respective ligands results in a 
conformational change allowing interaction with CARD domain containing receptor–
interacting serine-threonine kinase 2 (RIP2) in a homophilic CARD-CARD manner. Cellular 
inhibitors of apoptosis 1 and 2 (clAP1 and 2) are also involved (Kobayashi, Inohara et al. 2002). 
RIP2 can then mediate the ubiquitination of NFB essential modulator (NEMO)/IKK, 
subsequently leading to the activation of NFB and the production of pro-inflammatory 
cytokines and antimicrobial peptides (Inohara, Koseki et al. 2000). Activation of NOD2 by 
MDP also can result in the activation of the mitogen activated protein kinase (MAPK) 
pathways via the adapter CARD9 (Kobayashi, Chamaillard et al. 2005). 
5.3.1 The inflammasome 
Certain members of the NLR family detect microbial components in the cytosol and trigger 
the assembly of a large caspase 1 activating complex termed the inflammasome. This 
complex supports the autocatalytic cleavage of caspase-1 which enables the processing and 
secretion of IL-1 and IL-18. NLRP1, NLRP3, NLRC4 and the adapter apoptosis-associated 
speck-like protein containing a CARD (ASC) are critical components of the inflammasome 
but emerging components include NLRP6 (Bauernfeind 2011, Ablasser et al.; Kersse 2011, 
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Bertrand et al.; Franchi, Eigenbrod et al. 2009). While much of the focus has been on the 
caspase-1 inflammasome, other caspases are also associated with an inflammasome-triggered 
response in a caspase-1-independent manner (Kayagaki, Warming et al. 2011). 
The NLRP3 inflammasome is the most extensively studied: it comprises NLRP3, ASC, and 
caspase-1 (Martinon and Tschopp 2004). Like other NLRP family members, NLRP3 is 
composed of a C-terminal LRR domain, a central NOD domain and an N-terminal PYD 
domain. NLRP3 is expressed in many types of hematopoietic cells, in addition to 
osteoblasts, skin keratinocytes and transitional epithelium of the urinary tract (Elinav, 
Strowig et al. 2011). A wide variety of pathogens of bacterial, fungal and viral origin can 
initiate NLRP3 inflammasome formation: Listeria monocytogenes, Staphylococcus aureus, C. 
albicans, Saccharomyces cerevisiae, and adenovirus and influenza viruses. A number of host-
derived DAMPs indicative of cellular injury, including extracellular ATP and uric acid 
among others, have been shown to activate the inflammasome (Mariathasan, Weiss et al. 
2006; Gasse, Riteau et al. 2009). The mechanisms involved in the recognition of these stimuli 
by NLRP3 are currently not fully understood. Interaction of cellular mediators with a 
variety of PAMPs and DAMPs, ultimately relaying signals to NLRP3 has been postulated 
but physical interaction between NLRP3 and the PAMPs/DAMPs has not been ruled out 
(Marina-Garcia, Franchi et al. 2008). Following activation, NLRP3 oligomerisation leads to 
the clustering of PYD domains which can then recruit the CARD containing adaptor ASC 
which by a CARD-CARD interaction can then recruit pro-caspase-1. The clustering of pro-
capase-1 results in its autocleavage to the active caspase-1 p10/p20 tetramer enabling the 
processing of cytokine proforms to yield mature molecules for secretion. Production of these 
proforms depends on NFB driven transcriptional activity resulting from signalling from 
other PRRs such as NOD2 and TLRs (Schroder and Tschopp 2010). 
Less is known about the NLRP1 inflammasome, which is comprised of ASC, caspase-1, 
caspase-5, and NLRP1 (Martinon and Tschopp 2004). NLRP1 is expressed in various 
haematopoietic cells including: T and B cells, monocytes, dendritic cells and granulocytes, 
on non-haematopoietic cells within the testes, and neurons (Elinav, Strowig et al. 2011). The 
structure of NLRP1 is different to that of NLRP3, as NLRP1 contains a C-terminal CARD 
domain, allowing NLRP1 to interact directly with pro-caspase-1. However ASC forms part 
of the inflammasome complex, allowing for the recruitment of caspase-5 providing 
additional inflammasome activity (Martinon and Tschopp 2004). 
NLRC4 (also known as IPAF) is expressed primarily in lymphoid tissue. Like NOD1 and 
NOD2 it has a C-terminal LRR domain, a central NOD domain, and an N-terminal CARD 
domain (Hu, Elinav et al. 2010). Activation of the NLRC4 by microbial flagellin leads to the 
activation of caspase-1, IL-1 secretion and pyroptosis, a rapid form of cell death (Lightfield, 
Persson et al. 2008; Miao, Ernst et al. 2008). Similar to NLRP1, NLRC4 can interact directly with 
pro-caspase-1 via its CARD domain. The role of ASC in the NLRC4 inflammasome remains 
inconclusive: ASC cannot interact with NLRC4 which lacks a PYD domain but a role for ASC 
in regulation of this inflammasome has been suggested (Schroder and Tschopp 2010). 
5.4 RIG-l like Receptors (RLRs) 
The cytoplasmic RNA helicases that comprise the RIG-I like family of receptors play a major 
role in host anti-viral defence. RLRs include the highly characterised RIG-1 (retinoic acid-
inducible gene I), MDA5 (melanoma differentiation associated factor 5) and LGP2 
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(laboratory of genetics and physiology 2). These are able to detect a variety of viral RNA 
ligands present in the cytoplasm and triggering the activation of transcription factors 
resulting in the production of type 1 interferons (IFN) in addition to expression of other anti-
viral genes (Yoneyama and Fujita 2007). Viral recognition also occurs via TLR3. It seems that 
RIG-1 and MDA5 play a greater role in viral recognition by fibroblasts, macrophages and 
myeloid dendritic cells whereas TLR3 plays a more important role in viral recognition by 
plasmacytoid dendritic cells (Kato, Sato et al. 2005). 
Both RIG-1 and MDA5 share a number of structural similarities. They contain a central 
DExD/H box RNA helicase domain flanked by an N-terminal of tandem CARD domains 
and a C-terminal domain (CTD). In the case of RIG-1 the CTD also contains a repressor 
domain (RD), involved in autoregulation, which is not present in the CTD of MDA5. Despite 
their similar structures, RIG-1 and MDA5 are able to detect distinct viral species: RIG-1 is 
involved in the recognition of Paramyxoviridae, Filoviridae and Rhabdoviridae among 
others, whereas MDA5 is important in the recognition of Picornaviruses (Loo and Gale 
2011). More is known about RLR signalling in regard to RIG-1, however its believed that 
both RIG-1 and MDA5 share a common signalling pathway, involving the adaptor ISP-1 
(Kawai, Takahashi et al. 2005). Prior to recognition of RNA by the RD or CTD region, RIG-1 
is inactive in a ”closed” conformation, where the CARD domain is bound to the RD. 
Activation of RIG-1 results in a conformational change whereby CARD is released from the 
RD, allowing the CARD domain to interact with the adaptor ISP-1 (Loo and Gale 2011). ISP-
1 can then initiate two distinct signalling routes resulting in the activation of various 
transcription factors including NFB which induces the production of pro-inflammatory 
cytokines, and IRF3 and IRF7 which are responsible for the expression of type 1 IFNs (Kawai, 
Takahashi et al. 2005). Unlike RIG-1, MDA5 does not contain a RD to regulate its activation 
and when expressed ectopically signalling occurs in the absence of RNA recognition (Terness, 
Kallikourdis et al. 2007). Unlike RIG-I and MDA5, LGP2 lacks the N-terminal CARD domain, 
consisting only of the RNA helicase domain and the C-terminal domain containing an RD. It 
has been suggested that LGP2 is involved in the negative regulation of RIG-1 and possibly 
MDA5 (Loo and Gale 2011). This negative feedback is thought to take place on many levels 
including acting as a competitor for dsRNA, interaction with ISP-1, and maybe direct binding 
to RIG-1 via RD interactions (Terness, Kallikourdis et al. 2007).  
5.5 Other pattern recognition receptors 
Other less well characterised groups of pattern recognition receptors have also been 
described, including DAI (DNA dependent activator of IFN regulatory factors)-like 
receptors (DLRs) and scavenger receptors (SR). DAI (also known as DLM-1 and ZBP1) is the 
only DLR receptor to be described to date. It was first identified in mouse macrophages and 
mouse tumour stromal cells. DAI was up-regulated by exposure to cytosolic DNA or 
interferon gamma (IFN) suggesting that DAI functions as a DNA sensor (Fu, Comella et al. 
1999; Ishii, Coban et al. 2006). A human homologue containing two N-terminal Z domains 
and a C-terminal domain has since been described but it is of unknown function 
(Rothenburg, Schwartz et al. 2002). Activation of DAI by either microbial or host derived 
DNA, results in the activation of both the NFB pathway and the IRF pathway (Takaoka 
and Taniguchi 2008). 
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Scavenger receptors (SRs) are a group of cell surface transmembrane receptors that are 
important in the clearance of several pathogens, host modified molecules, and apoptotic 
cells by endocytotic internalisation. These receptors also play a role in lipid metabolism. 
Expressed primarily on myeloid cells and some endothelial cells, both their expression and 
structure are regulated by various cytokines. Numerous SRs have been shown to play a role 
in innate immunity, including SR-A I, SR-A II, CD36, LOX-1, MARCO, SR-CL I, SR-CL II, 
SCARF1 and DSR-C1 (Peiser, Mukhopadhyay et al. 2002; Means, Mylonakis et al. 2009). 
6. Pattern recognition receptors at the maternal-fetal interface 
The discovery of an association between intrauterine infection, inflammation and certain 
adverse pregnancy outcomes has lead to increased interest in the innate immune response at 
the maternal-fetal interface (Goncalves, Chaiworapongsa et al. 2002). The production by 
gestation-associated tissues of cytokines in response to microbial products has been well 
documented. Since pattern recognition receptors are a key component of the innate immune 
response, linking infection by various microorganisms to the production of inflammatory 
mediators, a role for PRRs at the maternal–fetal interface has been postulated. To date 
studies have principally focused on the role of TLRs and most recently NLRs, primarily in 
the placenta and the trophoblast.  
6.1 Placenta  
Expression of transcripts for TLR 1-10 in the term placenta has been demonstrated with all 
but TLR9 shown to be functional (note that TLR10 function has not been studied due to the 
lack of an identified ligand). Changes were observed in both mRNA expression and 
functional cytokine outputs in response to labour at term (Patni, Wynen et al. 2009). TLR2 
and TLR4 protein has been localised to term syncytiotrophoblast and intermediate 
trophoblast cells and both receptors are highly expressed in first trimester placental tissue 
(Holmlund, Cebers et al. 2002; Abrahams and Mor 2005). First trimester trophoblast cells 
also express TLR6. TLR6 blocks apoptosis induced by PGN via TLR1 and TLR2 and 
mediates NFB activation and secretion of IL-6 and IL-8 leading to the postulate that TLR6 
might regulate the balance of apoptosis and inflammation in response to Gram-positive 
infection (Abrahams, Aldo et al. 2008). 
The NLRs, NOD1 and NOD2 are both expressed in the first trimester placenta where they 
are localised to the syncytiotrophoblast and cytotrophoblast. In contrast only NOD1 is 
expressed in term trophoblast cells. This corresponds to the functional outputs of first 
versus third trimester trophoblast cells; first trimester cells respond to both MDP and iE- 
DAP, and third trimester cells only respond to iE-DAP (Abrahams 2011; Cardenas, Mulla et 
al. 2011). The NOD1 ligand, iEDAP, can induce preterm delivery in a murine model. When 
lower doses that did not induce preterm delivery were used there was heightened 
inflammation at the materno-fetal interface and in the fetus itself (Cardenas, Mulla et al. 
2011). Immunohistochemical studies have shown that the CLR DC-SIGN is expressed by 
fetal macrophages (Hofbauer cells) within the chorionic villi of the term placenta 
(Geijtenbeek, van Vliet et al. 2001). Viral ssRNA also activates cytokine, chemokine, and 
type I interferon production by primary first trimester trophoblast cells. This ligand also 
induces apoptosis in trophoblast cells in an IFN-dependent fashion (Aldo, Mulla et al. 
2010). 
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6.2 Amnion 
Amniotic epithelial cells represent the first line of defence against intra-amniotic infection. 
Earlier studies were restricted to TLR2 and TLR4 and found that both of these receptors are 
up-regulated in the amnion from women with chorioamnionitis compared to those without 
(Kim, Romero et al. 2004) although not all studies support this finding (Choi, Jung et al. 
2011). Transcripts for TLRs 1-10 have been detected in human amniotic epithelial cells. 
However only TLR2/6, TLR4 and TLR5 have been reported to be functional: activation of 
TLR2/6 and TLR5 resulted in increased production of IL-6 and IL-8, while activation of 
TLR4 reduced cell viability via apoptosis (Gillaux, Mehats et al. 2011). Immunohistochemical 
studies of human fetal membranes have shown that the expression of TLR4 is greater in the 
chorion than the amnion, that expression decreases with gestational age but that expression 
does not differ by anatomic location within the uterus (Choi, Jung et al. 2011).  
6.3 Decidua 
Despite its juxtaposition to the myometrium the expression and function of PRRs within the 
maternally derived decidua is not studied extensively. Transcripts for TLRs 1-6 have been 
detected in term decidual cells but only TLR1, TLR2, TLR4 and TLR6 where shown to be 
functional via production of IL-8 in response to stimulation with LPS or PGN (Canavan and 
Simhan 2007). Immunohistochemical studies have demonstrated the expression of NOD1 
and NOD2 in first trimester decidualised stroma (King, Horne et al. 2009). DC-SIGN has 
also been detected on decidual macrophages (Repnik, Tilburgs et al. 2008).  
7. PRRs and adverse pregnancy outcomes 
PRRs expressed at the maternal-fetal interface could play an important role in the 
pathogenesis of infection-associated preterm birth and other adverse pregnancy outcomes 
(Abrahams 2005a). This possibility has been studied mostly with regards to TLRs, especially 
TLR4. LPS from Gram-negative bacteria has been implicated in infection associated preterm 
birth and there have been a number of studies exploring the possible role of TLR4 in 
preterm labour. Functional TLR4 has been implicated in preterm labour triggered by 
administration of heat killed E.coli in mice (Wang and Hirsch 2003) . Evidence for a role for 
TLRs in infection-associated preterm birth also comes from genetic studies. A 
polymorphism (Asp299Gly) known to be associated with impaired TLR4 function and an 
increased likelihood of Gram-negative sepsis (Agnese DM 2002) was carried more often by 
preterm infants than term infants or by mothers delivering preterm than at term (Vacca, 
Cantoni et al. 2010). Genetic variation in TLRs is also associated with other adverse obstetric 
outcomes: TLR4, TLR9 and TLR1 but not TLR2 variants are associated with placental malaria 
(low birth weight and maternal anaemia; no difference in parasite densities) (Hamann, 
Bedu-Addo et al. 2010). Other genetic variants are also associated with risk of PTB: maternal 
genetic variants in extracellular matrix metabolism with risk of PPROM and fetal genetic 
variation (e.g. IL-6R1) are associated with risk of PTB (Romero, Friel et al. 2010). 
While LPS has been used as the model for many years it is worth noting that LPS from 
different species of bacteria might differentially regulate inflammatory responses from 
gestation-associated tissues such as the amniochorion (Chang, Jain et al. 2010). Also tissue 
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processing for ex vivo investigations can impact on cytokine measurements. For example, in 
a comparison of punch biopsies of amnion or choriodecidua versus dual compartment 
transwells, the punch biopsies typically made greater amounts of cytokines (Miller 2010. 
and Loch-Caruso). Such observations highlight the need to take these factors into account 
when designing studies and when comparing data from different studies. 
In addition to the direct pro-inflammatory effects initiated by exposure to infection, 
disturbances in the regulation of apoptosis might also be associated with sub-optimal 
pregnancy outcome (Jerzak and Bischof 2002). Increased trophoblast apoptosis is seen 
during the first trimester of pregnancies complicated with IUGR or preeclampsia (Saito, 
Kato et al. 1992; Smith, Baker et al. 1997), and elevated trophoblast apoptosis has been 
observed in preterm births (Kakinuma, Kuwayama et al. 1997; Balkundi, Ziegler et al. 2003). 
It has been suggested that the direct or indirect effects of infectious microorganisms upon 
trophoblast cell survival might depend upon which TLRs are activated with TLR2-mediated 
events presumably favouring apoptosis.  
Recently there has been growing interest in how a viral infection might itself cause preterm 
birth and also how it might increase the risk of pregnancy failure during subsequent or 
concurrent bacterial infection. In a murine model, intraperitoneal injection of a synthetic 
TLR3 ligand, poly I:C, caused preterm delivery within 24 hours. This was associated with 
inflammation in multiple gestation-associated tissues (polymorphonuclear cell infiltrate, 
necrosis and haemorrhage), infiltration of NK cells and macrophages into the placenta, and 
placental cytokine (e.g. IL-6) and chemokine (e.g. MCP-1) production that could also be 
detected systemically. This did not occur in TLR3 knock out animals. The cytokine response 
could be replicated in vitro by polyI:C treatment of primary murine trophoblast and a 
human trophoblast cell line and involved activation of NFB (Koga, Cardenas et al. 2009). In 
contrast, intra-peritoneal injection of murine herpes virus was associated with evidence of 
inflammation in the placenta and spleen but no adverse pregnancy outcomes. Evidence of 
viral infection in the placenta and decidua but not the fetus led the investigators to postulate 
that these tissues act as a barrier to capture virus and prevent infection of the fetus. 
However, this might not prevent developmental impacts on the fetus. Human primary first 
trimester trophoblast also can be infected with herpes virus in vitro but unlike the response 
to poly I:C treatment, cytokine and chemokine production tended to be down-regulated. 
Viral infection but not polyI:C induced increased expression of TLR2 and TLR4 in human 
trophoblast cells and in the accompanying mouse model, viral infection sensitised for a 
response – preterm delivery in less than 24hrs in all mice accompanied by 100% fetal death - 
to intraperitoneal infection of LPS (Cardenas 2010, 2011 respectively, Means et al.; Cardenas 
2010, 2011 respectively, Mor et al.). 
These observations have highlighted a need for better understanding of the expression and 
activity of viral detecting PRRs at the materno-fetal interface. Although the focus of this 
chapter is the placenta and attached membranes it is also worth noting that there is 
incredible interest in how anti-viral responses by women are affected by pregnancy.  
Preeclampsia, a pregnancy specific hypertensive disorder, also is characterised by 
inflammation. Pathways related to stress, inflammation (including TLR signalling 
pathways), growth, tissue remodelling, and metabolism are all altered during preeclampsia 
(Sado, Naruse et al. 2011). The differences might reflect acute inflammation secondary to 
microbial infection versus chronic inflammation secondary to oxidative stress. Possible 
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involvement of the inflammasome in preeclampsia has been suggested. Uric acid is known 
to activate the inflammasome: circulating uric acid levels increase prior to clinical 
manifestations of preeclampsia and levels relate to disease severity. Components of the 
inflammasome, including ASC, are expressed in first and third trimester trophoblasts and 
monosodium urate up-regulates IL-1 production in an inflammasome-dependent manner 
(Mulla, Myrtolli et al. 2011). There is also interest in the potential role of viral PAMPs or 
related DAMPs from necrotic cells in preeclampsia. Activation via TLR3 or the RLRs RIG-1 
and MDA-5 leading to downstream inflammation, anti-angiogenesis and oxidative stress 
converging on endothelial dysfunction has been postulated (Chatterjee, Weaver et al. 2011).  
8. Regulating the inflammatory response at the materno-fetal interface 
The resolution of inflammation is essential for immune homeostasis. It has become apparent 
that there are intracellular stress proteins that have extracellular properties related to the 
regulation of the innate immune response and inflammation. These so-called RAMPs 
(resolution-associated molecular patterns) (Shields, Panayi et al. 2011) have anti-
inflammatory activity or the ability to resolve inflammation and counterbalance the activity 
of PAMPs and DAMPs. There is keen interest in the potential therapeutic use of these.  
There are also a number of cytokines well recognised for their anti-inflammatory activity. 
These include IL-4, IL-10 and IL-13. IL-10 can down-regulate LPS- and LTA-induced 
cytokine/chemokine responses by the healthy term placenta (Bayraktar, Peltier et al. 2009). 
Paradoxically, IL-10 is increased in amniotic fluid from women in term labour and women 
with intra-amniotic infection at term and preterm, and is also increased in those without 
infection who delivered preterm rather than term (Gotsch, Romero et al. 2008). Elevated IL-
10 in these circumstances might represent a compensatory mechanism that has failed. 
Similarly, an anti-inflammatory cytokine (IL-4, IL-10 and IL-13) bias within the cervix prior 
to 16 weeks of gestation might identify those women most likely to suffer microbial invasion 
of the utero-placental unit and then spontaneous preterm labour and delivery (Simhan, 
Bodnar et al. 2011). Whether the greater anti-inflammatory milieu permits ascending 
infection or is a compensatory response to a pro-inflammatory response to existing infection 
that when no longer controlled tips in favour of the pro-inflammatory response and the 
initiation of labour remains to be determined.  
There is also a need to better understand the bioactivity of key cytokines at the materno-fetal 
interface. The biological effect of any cytokine depends on the expression of cognate 
receptors on target cells and this can be modified by the presence of soluble receptors, 
macromolecules that bind the cytokine, and the relative abundance of other cytokines. IL-6 
provides a relevant example. IL-6 is a multi-functional cytokine: while its pro- and anti-
inflammatory properties are of particular interest in the context of this review it is also 
involved in the acute phase reaction and regulates haematopoiesis. Classic signaling by IL-6 
is mediated via interaction with the non-signaling transmembrane IL-6 receptor followed by 
homodimerisation of signalling gp130. IL-6R-negative cells can utilize IL-6 trans-signaling 
via IL-6 binding to soluble IL-6R (sIL-6R) for interaction with membrane expressed gp130. 
The presence of soluble gp130 (sgp130) inhibits trans-signaling by offering an alternative 
binding site for IL-6/sIL-6R thereby prohibiting interaction with the membrane bound form 
of gp130 and downstream intracellular signalling. Although sgp130 cannot bind directly to 
IL-6 it has been shown recently to also inhibit classic signaling depending on the ratio of IL-
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6 and sIL-6R (Garbers, Thaiss et al. 2011). Human amniotic fluid contains IL-6, sIL-6R and 
sgp130 with levels of sgp130 declining with increasing gestational age. Amniotic fluid IL-6 
and sIL-6R are increased when there is evidence of intraamniotic infection: the fetal 
membranes are a key source of these mediators. Increased IL-6R, either membrane or 
soluble, combined with decreased sgp130 in intraamniotic infection would favour IL-6 pro-
inflammatory signalling. Indeed, sgp130 but not sIL-6R modulates LPS-mediated MMP9 
production by fetal membranes (Lee, Buhimschi et al. 2011). Reduced IL-6 trans-signalling 
mainly due to reduced circulating soluble gp130 also has been implicated in recurrent 
spontaneous abortion via a postulated role in modulating activity of regulatory T ell at 
materno-fetal interface (Arruvito, Billordo et al. 2009).  
9. Conclusion 
The study of PRR-mediated inflammation at the maternal-fetal interface has only just begun. 
A better understanding of these receptors and the signal transduction cascades they initiate 
might explain why some pregnancies are complicated by PTL and PPROM whereas others 
are only affected by PPROM. Moreover, investigations into the endogenous activators of 
PRRs might explain how PTL and PPROM can occur in the absence of infection (e.g. 
preeclampsia, multiple gestation, teenage pregnancy, or excessive tobacco and alcohol 
consumption). These molecules (either the receptors or their signalling molecules) might 
therefore be excellent targets for therapeutic strategies because they are upstream effectors 
of the pro-inflammatory cascade that ultimately results in premature labour and preterm 
birth. 
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